Jablons David M MD is categorized under Thoracic Doctors in San Francisco, CA and active since 2006.
Jablons David M MD was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Thoracic Doctors business, which does work in the B2C market, and is classified as a Thoracic Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David Jablons at the company’s single location by writing to 1600 Divisadero St, San Francisco, California CA 94115 or by phoning (415) 885-3882. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jablons David M MD |
| Contact Person: | David Jablons |
| Address: | 1600 Divisadero St, San Francisco, California 94115 |
| Phone Number: | (415) 885-3882 |
| Website Address: | thoracic.surgery.ucsf.edu |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Thoracic Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Jablons David M MD was started in 2006 to provide professional Thoracic Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Jablons for inquiries that concern Jablons David M MD by calling the company number (415) 885-3882, as your correspondence is most welcome. Additionally, the physical location of the single location of Jablons David M MD can be found at the coordinates 37.77512,-122.45186 as well as the street address 1600 Divisadero St in San Francisco, California 94115.
For its online presence, you may visit Jablons David M MD’s website at thoracic.surgery.ucsf.edu and engage with its social media outlets through on Twitter and on Facebook.